Efficacy and safety of antiretrovirals in HIV-infected patients with cancer.


At 30 years into the HIV infection epidemic, the optimal antiretroviral (ARV) regimen for infected patients with cancer remains unknown. We therefore sought to retrospectively study different ARV regimens used in this population. Data from HIV-infected patients seen at The University of Texas MD Anderson Cancer Center in Houston, Texas, USA, from 2001 to… (More)
DOI: 10.1111/1469-0691.12589